SMS Pharmaceuticals Ltd — Investor Relations & Filings
SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| General Updates | 2026-05-23 | English | |
| Investor Presentation | 2026-05-23 | English | |
| Press Release on Financial Results for the year ended 31.03.2026 | 2026-05-23 | English | |
| Press Release | 2026-05-23 | English | |
| Intimation of Investor Call | 2026-05-22 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-22 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46894503 | General Updates | 2026-05-23 | English | ||
| 46893043 | Investor Presentation | 2026-05-23 | English | ||
| 46891417 | Press Release on Financial Results for the year ended 31.03.2026 | 2026-05-23 | English | ||
| 46894540 | Press Release | 2026-05-23 | English | ||
| 46811545 | Intimation of Investor Call | 2026-05-22 | English | ||
| 46802004 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-22 | English | ||
| 46797616 | Please find the enclosure | 2026-05-22 | English | ||
| 46797148 | Address Change | 2026-05-22 | English | ||
| 46797192 | Statement of deviation(s) or variation(s) under Reg. 32 | 2026-05-22 | English | ||
| 46797694 | Please find the enclosure | 2026-05-22 | English | ||
| 46797751 | Re-appointment of Auditors of the Company | 2026-05-22 | English | ||
| 46797266 | Change in Auditors | 2026-05-22 | English | ||
| 46788008 | Dividend | 2026-05-22 | English | ||
| 46788002 | Declaration of Dividend for the financial year 2025-26 | 2026-05-22 | English | ||
| 46784400 | Integrated Filing- Financial | 2026-05-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aquestive Therapeutics, Inc.
Pharmaceutical company developing oral film medicines for C…
|
AQST | US | Manufacturing |
|
Arbutus Biopharma Corp
Clinical-stage biopharma company developing a functional cu…
|
ABUS | US | Manufacturing |
|
Arcellx, Inc.
A clinical-stage biotech company developing immunotherapies…
|
ACLX | US | Manufacturing |
|
Arctic Bioscience
Develops pharmaceutical and nutraceutical products from mar…
|
ABS | NO | Manufacturing |
|
ArcticZymes Technologies
Develops and manufactures novel recombinant enzymes from Ar…
|
AZT | NO | Manufacturing |
|
Arcturus Therapeutics Holdings Inc.
A commercial-stage mRNA medicines company focused on rare a…
|
ARCT | US | Manufacturing |
|
Arcus Biosciences, Inc.
A clinical-stage biopharmaceutical company developing combi…
|
RCUS | US | Manufacturing |
|
Arcutis Biotherapeutics, Inc.
Develops and commercializes treatments for immune-mediated …
|
ARQT | US | Manufacturing |
|
ARDELYX, INC.
Biopharmaceutical company developing medicines for cardiore…
|
ARDX | US | Manufacturing |
|
ARECOR THERAPEUTICS PLC
Biopharmaceutical company enhancing medicines with its prop…
|
AREC | GB | Manufacturing |
SMS Pharmaceuticals Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62302/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62302 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62302 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62302 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62302}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SMS Pharmaceuticals Ltd (id: 62302)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.